Ganymed Pharmaceuticals

Astellas snaps up cancer antibody play Ganymed for up to $1.4B

Astellas Pharma expects to beef up its oncology franchise with the purchase of German biotech Ganymed Pharmaceuticals for what could be a total of $1.4 billion.

Stacy Lawrence Oct 28, 2016 10:06am

Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drug

Jun 5, 2016 7:16am